General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

HSE targets 2008-2015

Novartis sets Health, Safety and Environment (HSE) targets covering periods of at least three years to allow better analysis, planning and implementation. For 2008-2015, the following targets have been defined on Group level:

Halogenated volatile organic compounds (VOCs)
Decrease to 130 tons in 2015 (-45% compared to 2008).
Non-halogenated volatile organic compounds (VOCs)
Decrease to 1,000 tons by 2015 (-40% compared to 2008).
Energy efficiency
Improve by 15% by 2015, compared to 2010.
Initiate water saving programs at the 10 sites with highest water footprint and water scarcity
Intensity of hazardous waste not recycled
Reduce by 10% by 2015, compared to 2010.
Intensity of non-hazardous waste not recycled
Reduce by 10% by 2015, compared to 2010.
Hazardous waste to landfill
Zero
Carbon dioxide (CO2) from vehicles
Decrease by 20% by 2015, based on 2010 level.
On-site Scope 1 greenhouse gas (GHG) emissions from operations, including carbon offsets.
Decrease to 293t (5% below 1990 level by 2012).
Total GHG emissions
Reduce by 15% by 2015 and 20% by 2020, including carbon offsets.
Lost Time Injury & Illness Rate (LTIR)
Reduce to less than or equal to 0.14 in 2013.
Total recordable case rate (TRCR)
Improve by 5% compared to Group performance in 2012.

Furthermore, the Group is pursuing the following goals:

  • Behavior-based safety programs initiated at all major Novartis sites
  • Waste minimization and water efficiency programs active in all divisions
  • Business continuity management program fully implemented worldwide
  • Risk reduction measures started and business continuity plans established for all remaining risks (according to risk portfolios)
  • Novartis emergency management programs implemented at divisional level as well as in all smaller units
  • Implementation of Be Healthy, the Novartis health and well-being initiative, at all sites with more than 100 associates

Related links: